223 related articles for article (PubMed ID: 9184925)
1. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.
Noto H; Takahashi T; Makiguchi Y; Hayashi T; Hinoda Y; Imai K
Int Immunol; 1997 May; 9(5):791-8. PubMed ID: 9184925
[TBL] [Abstract][Full Text] [Related]
2. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.
Takahashi T; Makiguchi Y; Hinoda Y; Kakiuchi H; Nakagawa N; Imai K; Yachi A
J Immunol; 1994 Sep; 153(5):2102-9. PubMed ID: 8051415
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site.
Wright SE; Kilinski L; Talib S; Lowe KE; Burnside JS; Wu JY; Dolby N; Dombrowski KE; Lebkowski JS; Philip R
J Immunother; 2000 Jan; 23(1):2-10. PubMed ID: 10687132
[TBL] [Abstract][Full Text] [Related]
4. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.
Stepensky D; Tzehoval E; Vadai E; Eisenbach L
Clin Exp Immunol; 2006 Jan; 143(1):139-49. PubMed ID: 16367945
[TBL] [Abstract][Full Text] [Related]
5. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
[TBL] [Abstract][Full Text] [Related]
6. Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA.
Milazzo C; Reichardt VL; Müller MR; Grünebach F; Brossart P
Blood; 2003 Feb; 101(3):977-82. PubMed ID: 12393470
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.
Brossart P; Heinrich KS; Stuhler G; Behnke L; Reichardt VL; Stevanovic S; Muhm A; Rammensee HG; Kanz L; Brugger W
Blood; 1999 Jun; 93(12):4309-17. PubMed ID: 10361129
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells.
Magarian-Blander J; Hughey RP; Kinlough C; Poland PA; Finn OJ
Glycoconj J; 1996 Oct; 13(5):749-56. PubMed ID: 8910002
[TBL] [Abstract][Full Text] [Related]
9. Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes.
Ciborowski P; Konitzki WM; Blander JM; Finn OJ
Tumour Biol; 1998; 19 Suppl 1():147-51. PubMed ID: 9422100
[TBL] [Abstract][Full Text] [Related]
10. Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8+ T-cells.
Roulois D; Vignard V; Gueugnon F; Labarrière N; Grégoire M; Fonteneau JF
Eur Respir J; 2011 Nov; 38(5):1117-26. PubMed ID: 21540305
[TBL] [Abstract][Full Text] [Related]
11. Retention of immunogenicity produced by mucin 1 peptides with glycosylation site substitutions.
Wright SE; Quinlin IS; Rewers-Felkins KA; Dombrowski KE; Phillips CA
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):647-55. PubMed ID: 20470225
[TBL] [Abstract][Full Text] [Related]
12. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Kawaoka T; Oka M; Takashima M; Ueno T; Yamamoto K; Yahara N; Yoshino S; Hazama S
Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
[TBL] [Abstract][Full Text] [Related]
13. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
Brossart P; Schneider A; Dill P; Schammann T; Grünebach F; Wirths S; Kanz L; Bühring HJ; Brugger W
Cancer Res; 2001 Sep; 61(18):6846-50. PubMed ID: 11559560
[TBL] [Abstract][Full Text] [Related]
14. Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes.
Müller MR; Grünebach F; Nencioni A; Brossart P
J Immunol; 2003 Jun; 170(12):5892-6. PubMed ID: 12794115
[TBL] [Abstract][Full Text] [Related]
15. CTL in mice immunized with human mucin 1 are MHC-restricted.
Apostolopoulos V; Loveland BE; Pietersz GA; McKenzie IF
J Immunol; 1995 Dec; 155(11):5089-94. PubMed ID: 7594517
[TBL] [Abstract][Full Text] [Related]
16. Mucin-1-related T cell infiltration in colorectal carcinoma.
Mulder WM; Stukart MJ; de Windt E; Wagstaff J; Scheper RJ; Bloemena E
Cancer Immunol Immunother; 1996 Jul; 42(6):351-6. PubMed ID: 8830738
[TBL] [Abstract][Full Text] [Related]
17. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1.
Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ
J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265
[TBL] [Abstract][Full Text] [Related]
18. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
Carmon L; El-Shami KM; Paz A; Pascolo S; Tzehoval E; Tirosh B; Koren R; Feldman M; Fridkin M; Lemonnier FA; Eisenbach L
Int J Cancer; 2000 Feb; 85(3):391-7. PubMed ID: 10652432
[TBL] [Abstract][Full Text] [Related]
19. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL
Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429
[TBL] [Abstract][Full Text] [Related]
20. MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells.
Wright SE; Rewers-Felkins KA; Quinlin IS; Fogler WE; Phillips CA; Townsend M; Robinson W; Philip R
Immunol Invest; 2008; 37(3):215-25. PubMed ID: 18389441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
